Curis, Inc. (CRIS)
1.08
+0.02
(+1.89%)
USD |
NASDAQ |
Feb 12, 16:00
1.10
+0.02
(+1.85%)
Pre-Market: 08:07
Curis Free Cash Flow : -30.09M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agenus, Inc. | -89.31M |
| LadRx Corp. | -- |
| Windtree Therapeutics, Inc. | -15.12M |
| Enzon Pharmaceuticals, Inc. | -2.102M |
| Halozyme Therapeutics, Inc. | 602.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.569M |
| Cash from Financing (Quarterly) | 4.482M |
| Free Cash Flow Per Share (Quarterly) | -0.3552 |
| Free Cash Flow to Equity (Quarterly) | -3.702M |
| Free Cash Flow to Firm (Quarterly) | -4.684M |
| Free Cash Flow Yield | -250.6% |